Search Results - "MARTIN KAST, W."

Refine Results
  1. 1

    Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials by Monk, Bradley J., Enomoto, Takayuki, Kast, W. Martin, McCormack, Mary, Tan, David S.P., Wu, Xiaohua, González-Martín, Antonio

    Published in Cancer treatment reviews (01-05-2022)
    “…•Two immunotherapies for recurrent/metastatic cervical cancer were approved in 2021.•Several trials are anticipated in recurrent/metastatic and locally…”
    Get full text
    Journal Article
  2. 2

    Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response by Skeate, Joseph G, Da Silva, Diane M, Chavez-Juan, Elena, Anand, Snjezana, Nuccitelli, Richard, Kast, W Martin

    Published in PloS one (11-01-2018)
    “…Nano-Pulse Stimulation (NPS) is a non-thermal pulsed electric field modality that has been shown to have cancer therapeutic effects. Here we applied NPS…”
    Get full text
    Journal Article
  3. 3

    Annexin A2 in Virus Infection by Taylor, Julia R, Skeate, Joseph G, Kast, W Martin

    Published in Frontiers in microbiology (05-12-2018)
    “…Viral life cycles consist of three main phases: (1) attachment and entry, (2) genome replication and expression, and (3) assembly, maturation, and egress. Each…”
    Get full text
    Journal Article
  4. 4

    Identifying the intersection of parental HPV and COVID-19 vaccine hesitancy to inform health messaging interventions in community-based settings by Garcia, Samantha, Shin, Michelle, Gill, Morgan, He, Zehui, Dang, Emily, Kast, W. Martin, Unger, Jennifer B., Baezconde-Garbanati, Lourdes, Tsui, Jennifer

    Published in Vaccine (14-11-2024)
    “…•We observed parents with high HPV vaccine hesitancy reported lower intent to have their child receive the COVID-19 vaccine.•Parents that were reluctant to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Evolving Field of Human Papillomavirus Receptor Research: a Review of Binding and Entry by Raff, Adam B, Woodham, Andrew W, Raff, Laura M, Skeate, Joseph G, Yan, Lisa, Da Silva, Diane M, Schelhaas, Mario, Kast, W Martin

    Published in Journal of Virology (01-06-2013)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy by Skeate, Joseph G, Otsmaa, Mikk E, Prins, Ruben, Fernandez, Daniel J, Da Silva, Diane M, Kast, W Martin

    Published in Frontiers in immunology (15-05-2020)
    “…Tumor necrosis factor superfamily member 14 (LIGHT) has been in pre-clinical development for over a decade and shows promise as a modality of enhancing…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Examining multilevel influences on parental HPV vaccine hesitancy among multiethnic communities in Los Angeles: a qualitative analysis by Shin, Michelle B, Sloan, Kylie E, Martinez, Bibiana, Soto, Claradina, Baezconde-Garbanati, Lourdes, Unger, Jennifer B, Kast, W Martin, Cockburn, Myles, Tsui, Jennifer

    Published in BMC public health (22-03-2023)
    “…Human papillomavirus (HPV) vaccine hesitancy is a growing concern in the United States, yet understudied among racial/ethnic minority parents. We conducted…”
    Get full text
    Journal Article
  10. 10

    The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection by Woodham, Andrew W, Da Silva, Diane M, Skeate, Joseph G, Raff, Adam B, Ambroso, Mark R, Brand, Heike E, Isas, J Mario, Langen, Ralf, Kast, W Martin

    Published in PloS one (22-08-2012)
    “…Mucosotropic, high-risk human papillomaviruses (HPV) are sexually transmitted viruses that are causally associated with the development of cervical cancer. The…”
    Get full text
    Journal Article
  11. 11

    Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease by Da Silva, Diane M., Skeate, Joseph G., Chavez-Juan, Elena, Lühen, Kim P., Wu, Jiun-Ming, Wu, Chia-Mao, Kast, W. Martin, Hwang, KinKai

    Published in Vaccine (16-05-2019)
    “…Persistent human papillomavirus (HPV) infection is causally linked to the development of several human cancers, including cervical, vulvar, vaginal, anal,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression by García-Hernández, María de la Luz, Uribe-Uribe, Norma Ofelia, Espinosa-González, Ricardo, Kast, W Martin, Khader, Shabaana A, Rangel-Moreno, Javier

    Published in Frontiers in immunology (17-05-2017)
    “…Multiple solid cancers contain tertiary lymphoid organs (TLO). However, it is unclear whether they promote tumor rejection, facilitate tumor evasion, or simply…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mechanisms used by human papillomaviruses to escape the host immune response by Kanodia, Shreya, Fahey, Laura M, Kast, W Martin

    Published in Current cancer drug targets (01-02-2007)
    “…The greatest risk factor for the development of cervical and other cancers that have been linked to the human papillomavirus (HPV) family is the persistence of…”
    Get more information
    Journal Article
  16. 16

    Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human Papillomavirus by Da Silva, Diane M., Martinez, Emma A., Bogaert, Lies, Kast, W. Martin

    Published in Cancers (01-09-2022)
    “…Therapeutic vaccine studies should be designed to elicit durable, high magnitude, and efficacious T cell responses, all of which can be impacted by the choice…”
    Get full text
    Journal Article
  17. 17

    Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment by Woodham, Andrew W, Skeate, Joseph G, Sanna, Adriana M, Taylor, Julia R, Da Silva, Diane M, Cannon, Paula M, Kast, W Martin

    Published in AIDS patient care and STDs (01-07-2016)
    “…In the last three decades, extensive research on human immunodeficiency virus (HIV) has highlighted its capability to exploit a variety of strategies to enter…”
    Get more information
    Journal Article
  18. 18

    Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity by DE LA LUZ GARCIA-HEMANDEZ, Maria, GRAY, Andrew, HUBBY, Bolyn, KLINGER, Otto J, KAST, W. Martin

    Published in Cancer research (Chicago, Ill.) (01-02-2008)
    “…Prostate stem cell antigen (PSCA) is an attractive antigen to target using therapeutic vaccines because of its overexpression in prostate cancer, especially in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions by Kanodia, Shreya, Da Silva, Diane M., Kast, W. Martin

    Published in International journal of cancer (15-01-2008)
    “…Human papillomavirus (HPV)‐induced lesions are distinct in that they have targetable foreign antigens, the expression of which is necessary to maintain the…”
    Get full text
    Journal Article